Skip to main content
Premium Trial:

Request an Annual Quote

Pennsylvania Bio Offers Group Buying for Fisher Scientific Products

NEW YORK (GenomeWeb News) – Pennsylvania Bio, an association that promotes the state’s biotechnology business, has reached an agreement with Thermo Fisher Scientific under which its members will have group purchasing power for Fisher Scientific’s laboratory products, Pennsylvania Bio President Mickey Flynn said today.
The agreement gives Pennsylvania Bio members access to the Fisher Scientific catalog, and it allows the organization to offer members a portal for electronic purchases, portfolio management, needs assessments, e-commerce initiatives, and inventory and chemical management, Pennsylvania Bio said in a statement.
Flynn told GenomeWeb Daily News that, in aggregate, the group purchasing program could help Pennsylvania Bio’s roughly 330 members realize savings of around 10 percent on its Fisher Scientific purchases. 
“This partnership encompasses and helps to advance our central goal — to ensure Pennsylvania remains a global leader in biosciences,” Flynn added in a statement.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.